PresseMitteilungen CategoriesNewBiotechCategory / Pharmaceuticals & Biotech / Biotech Atossa Genetics to Present at the 9th Annual LD Micro Main Event Conference on December 7, 2016 SEATTLE, WA: ... Trillium Therapeutics Announces Conference Call and Webcast on December 5th to Discuss TTI-621 Data Presented at ASH TORONTO, ONTARIO: ... Sermonix Pharmaceuticals to Present Poster on Physician Perceptions of Menopausal SERMs at San Antonio Breast Cancer Symposium COLUMBUS, OH: ... ANGLE plc: Issue of Share Options GUILDFORD, SURREY: ... Marina Biotech to Present at the 9th Annual LD Micro Main Event BOTHELL, WA: ... ANGLE plc: Result of GM GUILDFORD, UNITED KINGDOM: ... Ceapro Inc. Reports Third Quarter 2016 Financial and Operational Results EDMONTON, ALBERTA: ... Medgenics to Present at the 28th Annual Piper Jaffray Healthcare Conference PHILADELPHIA, PA: ... Aldeyra Therapeutics to Present at the 28th Annual Piper Jaffray Healthcare Conference LEXINGTON, MA: ... The European Medicines Agency Grants Orphan Drug Designation Status to Immunovaccine''s DPX-Survivac in Ovarian Cancer HALIFAX, NOVA SCOTIA: ... Opthea Completes Patient Enrolment in Phase 1/2A wet AMD Clinical Trial MELBOURNE, AUSTRALIA: ... Marina Biotech Announces Merger with IthenaPharma BOTHELL, WA: ... Prevtec Microbia Receives Positive Final Opinion from European Medicines Agency for Coliprotec(R) F4/F18 for pigs MONTREAL, QUEBEC: First oral bivalent live vaccine for immunization of pigs against F4 and F18 Escherichia coli post-weaning diarrhea ... Atossa Genetics Announces Third Quarter 2016 Financial Results and Provides Company Update SEATTLE, WA: Conference Call to be Held Monday, November 14, 2016 at 5:30pm Eastern Time ... Taconic Biosciences to Breed and Distribute Three Copy Number Variant Models for Neurodevelopmental Disorder Studies HUDSON, NY: Models Were Custom Generated by Taconic and Validated in Collaboration with Innovative Medicines Initiative (IMI) ... VBI Vaccines Reports Rapid Seroprotection Results from an Interim Analysis of a Phase IV Postmarketing Study of its Sci-B-Vac(TM) Hepatitis B Vaccine CAMBRIDGE, MASSACHUSETTS: 98.8% of Patients Seroprotected at Two Months Following Second Dose of Sci-B-Vac(TM) ... Aldeyra Therapeutics Announces Third Quarter 2016 Financial Results LEXINGTON, MA: On Track to Initiate Two Phase II and Two Phase III Trials in 2017 ... Immunovaccine to Present at 2016 Biotech & Money Showcase Conference HALIFAX, NOVA SCOTIA: ... iBio Expands Product Development Capacity of cGMP Plant NEW YORK, NY: ... VBI Vaccines to Present at the Society of Neuro-Oncology Annual Meeting CAMBRIDGE, MASSACHUSETTS: ... Page 20 von 247: 1 « .. 19 20 21 22 23 24 25 26 27 28 .. » 247